α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies

α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies

Like many neurodegenerative diseases, Parkinson’s disease (PD) is characterized by the formation of proteinaceous aggregates in brain cells. In PD, those proteinaceous aggregates are formed by the α-synuclein (αSyn) and are considered the trademark of this neurodegenerative disease. In addition to P...

Full description

Bibliographic Details
Main Authors:	Noah J. Graves, Yann Gambin, Emma Sierecki
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	International Journal of Molecular Sciences
Subjects:	α-synuclein amyloid fibrils Parkinson’s disease dementia with Lewy bodies multiple system atrophy strain
Online Access:	https://www.mdpi.com/1422-0067/24/15/12134

Similar Items

Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
by: Sebastian Johannes Müller, et al.
Published: (2023-03-01)

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models
by: Melina J. Lim, et al.
Published: (2023-10-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
by: Berkiye Sonustun, et al.
Published: (2022-03-01)

Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia
by: Chang-ki Oh, et al.
Published: (2022-12-01)

Gender differences in Parkinson's disease with dementia and dementia with Lewy bodies
by: Lidadi L. Agbomi, et al.
Published: (2022-12-01)

Inflammation in dementia with Lewy bodies
by: Jay Amin, et al.
Published: (2022-06-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

Clinical biomarkers for Lewy body diseases
by: Mai M. Abdelmoaty, et al.
Published: (2023-11-01)

Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review
by: Paula M. Loveland, et al.
Published: (2023-07-01)

Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro
by: Masatoshi Inden, et al.
Published: (2021-10-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
by: Anna Emdina, et al.
Published: (2022-05-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
by: Arati Tripathi, et al.
Published: (2021-12-01)

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
by: Laura Marsal-García, et al.
Published: (2021-01-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

Lewy Body Dementias: A Coin with Two Sides?
by: Ángela Milán-Tomás, et al.
Published: (2021-06-01)

Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD
by: Michiyo Iba, et al.
Published: (2022-09-01)

Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies
by: Tu, Haitao, et al.
Published: (2022)

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
by: Grace M. Lloyd, et al.
Published: (2023-07-01)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

β-Synuclein: An Enigmatic Protein with Diverse Functionality
by: Junna Hayashi, et al.
Published: (2022-01-01)

Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings
by: Bethany Peterson, et al.
Published: (2019-03-01)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
by: Moeko Noguchi-Shinohara, et al.
Published: (2023-06-01)

Dementia with Lewy bodies
by: O. S. Levin, et al.
Published: (2018-11-01)

Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onset
by: Niels Hansen, et al.
Published: (2022-10-01)

Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
by: Matthieu Lilamand, et al.
Published: (2022-11-01)

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
by: Michiyo Iba, et al.
Published: (2024-04-01)

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
by: Carmen Peña-Bautista, et al.
Published: (2023-05-01)

Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders
by: Stefan Bräuer, et al.
Published: (2023-10-01)

Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases
by: V. N. Salkov, et al.
Published: (2024-01-01)

Cognitive impairment and dementia in parkinson's disease /
Published: (2010)

Alpha Synuclein: Neurodegeneration and Inflammation
by: Gianluigi Forloni
Published: (2023-03-01)

Norovirus Intestinal Infection and Lewy Body Disease in an Older Patient with Acute Cognitive Impairment
by: Manuel Moreno-Valladares, et al.
Published: (2022-07-01)

Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics
by: Jing Xu, et al.
Published: (2023-03-01)

A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson’s disease and dementia with Lewy bodies
by: R. Bhome, et al.
Published: (2024-01-01)

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
by: Masahito Yamada, et al.
Published: (2020-01-01)

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
by: Kamil Saramowicz, et al.
Published: (2023-12-01)

α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword
by: Li Yang Tan, et al.
Published: (2022-03-01)